Access & Optionality: Multiple Diagnostic Pathways to Expand Patient Reach
3:40 pm - Tuesday 6th October 2026
- This high-level talk challenges the outdated, one-size-fits-all diagnostic paradigm in precision medicine. It demonstrates how co-developing both LDT and CDx pathways simultaneously can dramatically expand patient access and de-risk drug development timelines
- Attendees will discover how leveraging extensive clinical trial capabilities and commercial networks can help maximize the global reach of novel therapeutics